APVO436 Phase 1b/2 Study in Patients With Newly Diagnosed AML
Clinical trial NCT06634394 · RECRUITING
Trial details
- NCT number
- NCT06634394
- Sponsor
- Aptevo Therapeutics
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-01
- Primary completion
- 2027-10-01
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.